Symptomatic Management of Tamaka Swasa[Bronchial Asthma] Through Ayurveda

An Exploratory Study to Evaluate The efficacy of Vyaghrijeerakavaleha in The Symptomatic Management of Tamaka Swasa[Bronchial Asthma] - Interventional Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082962

Enrollment

Registered

2025-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Chronicity-above 18 years.patient willing to sign the consent form. The patients between the age group of 18 to 70 years of either sex presenting with clinical feature of Tamak Swasa like,breathlessness,wheeze,paroxysm of attack,cough etc.irrespective of sex and religion

Exclusion criteria

Exclusion criteria: Age below and above 70 years.patients having Asthma due to secondary cause such as drug induced like aspirin.pregnant women and lactating mothers.Patient having concomitant systemic illness like uncontrolled hypertension,poorly controlled diabetes mellitus,renal failure,malignancy,acute or chronic liver disease.

Design outcomes

Primary

Measure	Time frame
To Assessment of subjective and objective parameters before and after treatmentTimepoint: from base line 15th day,30th day,45th day,60th day	—

Secondary

Measure	Time frame
To observe any side effects if occur during clinical trialTimepoint: from base line 15th day,30th day,45th day,60th day	—

Countries

India

Contacts

Public ContactDr Pramod Kumar Mishra

Post Graduate Institute of Ayurveda,jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results